These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 30396272

  • 1. Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.
    Li S, Cai Z, Wu X, Holden D, Pracitto R, Kapinos M, Gao H, Labaree D, Nabulsi N, Carson RE, Huang Y.
    ACS Chem Neurosci; 2019 Mar 20; 10(3):1544-1554. PubMed ID: 30396272
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A).
    Li S, Cai Z, Zhang W, Holden D, Lin SF, Finnema SJ, Shirali A, Ropchan J, Carre S, Mercier J, Carson RE, Nabulsi N, Huang Y.
    Eur J Nucl Med Mol Imaging; 2019 Aug 20; 46(9):1952-1965. PubMed ID: 31175396
    [Abstract] [Full Text] [Related]

  • 3. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16.
    Zheng C, Holden D, Zheng MQ, Pracitto R, Wilcox KC, Lindemann M, Felchner Z, Zhang L, Tong J, Fowles K, Finnema SJ, Nabulsi N, Carson RE, Huang Y, Cai Z.
    Eur J Nucl Med Mol Imaging; 2022 Apr 20; 49(5):1482-1496. PubMed ID: 34761284
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y.
    J Nucl Med; 2016 May 20; 57(5):777-84. PubMed ID: 26848175
    [Abstract] [Full Text] [Related]

  • 5. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O.
    Mol Imaging Biol; 2019 Jun 20; 21(3):509-518. PubMed ID: 30084043
    [Abstract] [Full Text] [Related]

  • 6. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
    Patel S, Knight A, Krause S, Teceno T, Tresse C, Li S, Cai Z, Gouasmat A, Carroll VM, Barret O, Gottmukkala V, Zhang W, Xiang X, Morley T, Huang Y, Passchier J.
    Mol Imaging Biol; 2020 Aug 20; 22(4):832-841. PubMed ID: 31728839
    [Abstract] [Full Text] [Related]

  • 7. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
    Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM.
    J Cereb Blood Flow Metab; 2021 Apr 20; 41(4):819-830. PubMed ID: 32538280
    [Abstract] [Full Text] [Related]

  • 8. Imaging of Synaptic Density in Neurodegenerative Disorders.
    Carson RE, Naganawa M, Toyonaga T, Koohsari S, Yang Y, Chen MK, Matuskey D, Finnema SJ.
    J Nucl Med; 2022 Jun 20; 63(Suppl 1):60S-67S. PubMed ID: 35649655
    [Abstract] [Full Text] [Related]

  • 9. First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.
    Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE.
    J Nucl Med; 2021 Apr 20; 62(4):561-567. PubMed ID: 32859701
    [Abstract] [Full Text] [Related]

  • 10. Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.
    Li S, Naganawa M, Pracitto R, Najafzadeh S, Holden D, Henry S, Matuskey D, Emery PR, Cai Z, Ropchan J, Nabulsi N, Carson RE, Huang Y.
    Eur J Nucl Med Mol Imaging; 2021 May 20; 48(5):1327-1338. PubMed ID: 33416954
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
    Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, Mievis F, Mestdagh N, Buchanan T, Valade A, Mercier J, Wood M, Gillard M, Seret A, Luxen A, Salmon E, Plenevaux A.
    J Nucl Med; 2014 Aug 20; 55(8):1336-41. PubMed ID: 24935992
    [Abstract] [Full Text] [Related]

  • 12. Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET).
    Rossano S, Toyonaga T, Berg E, Lorence I, Fowles K, Nabulsi N, Ropchan J, Li S, Ye Y, Felchner Z, Kukis D, Huang Y, Benveniste H, Tarantal AF, Groman S, Carson RE.
    Eur J Nucl Med Mol Imaging; 2022 Sep 20; 49(11):3679-3691. PubMed ID: 35633376
    [Abstract] [Full Text] [Related]

  • 13. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, Najafzadeh S, Ropchan J, Lu Y, McDonald JW, Michalak HR, Nabulsi NB, Arnsten AFT, Huang Y, Carson RE, van Dyck CH.
    JAMA Neurol; 2018 Oct 01; 75(10):1215-1224. PubMed ID: 30014145
    [Abstract] [Full Text] [Related]

  • 14. Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice.
    Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Liu L, Skinbjerg M, Munoz-Sanjuan I, Staelens S.
    J Cereb Blood Flow Metab; 2020 Jun 01; 40(6):1351-1362. PubMed ID: 31307287
    [Abstract] [Full Text] [Related]

  • 15. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
    Nicolas JM, Hannestad J, Holden D, Kervyn S, Nabulsi N, Tytgat D, Huang Y, Chanteux H, Staelens L, Matagne A, Mathy FX, Mercier J, Stockis A, Carson RE, Klitgaard H.
    Epilepsia; 2016 Feb 01; 57(2):201-9. PubMed ID: 26663401
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET.
    Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, Mievis F, Giacomelli F, Lemaire C, Salmon E, Luxen A, Plenevaux A.
    Molecules; 2019 May 01; 24(9):. PubMed ID: 31052478
    [Abstract] [Full Text] [Related]

  • 17. Novel 18F-Labeled κ-Opioid Receptor Antagonist as PET Radiotracer: Synthesis and In Vivo Evaluation of 18F-LY2459989 in Nonhuman Primates.
    Li S, Cai Z, Zheng MQ, Holden D, Naganawa M, Lin SF, Ropchan J, Labaree D, Kapinos M, Lara-Jaime T, Navarro A, Huang Y.
    J Nucl Med; 2018 Jan 01; 59(1):140-146. PubMed ID: 28747521
    [Abstract] [Full Text] [Related]

  • 18. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
    Gillard M, Chatelain P, Fuks B.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):102-8. PubMed ID: 16556440
    [Abstract] [Full Text] [Related]

  • 19. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.
    Bertoglio D, Verhaeghe J, Wyffels L, Miranda A, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M, Bard J, Liu L, Munoz-Sanjuan I, Staelens S.
    J Nucl Med; 2022 Jun 24; 63(6):942-947. PubMed ID: 34531262
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F, Giacomelli F, Degueldre C, Hustinx R, Luxen A, Seret A, Plenevaux A, Salmon E.
    Mol Imaging Biol; 2015 Aug 24; 17(4):557-64. PubMed ID: 25595813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.